Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 98.78% institutional investors, 1.43% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.86% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kura Oncology | 98.78% | 1.43% | -0.21% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 10.51M | 11.86% | $115.29M |
| Suvretta capital management | 8.58M | 9.68% | $94.07M |
| Bvf inc/il | 8.45M | 9.53% | $92.65M |
| Blackrock | 6.97M | 8.30% | $143.43M |
| Vanguard group | 5.51M | 6.28% | $57.22M |
| State street | 5.33M | 6.01% | $58.46M |
| Vanguard capital management | 3.92M | 4.42% | $42.96M |
| Armistice capital | 3.68M | 4.15% | $40.35M |
| Aqr capital management | 3.13M | 3.53% | $34.30M |
| Goldman sachs group | 2.27M | 2.56% | $24.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alethea capital management | 2.17M | 9.85% | $23.78M |
| Prosight management, lp | 2.02M | 3.82% | $22.18M |
| Ally bridge group (ny) | 290.00K | 2.81% | $3.18M |
| Lion point capital, lp | 46.00K | 2.41% | $504.62K |
| Bvf inc/il | 8.45M | 2.37% | $92.65M |
| Suvretta capital management | 8.58M | 1.72% | $94.07M |
| 1492 capital management | 467.15K | 1.51% | $5.12M |
| Nan fung trinity (hk) | 1.17M | 1.27% | $12.89M |
| Boxer capital | 1.00M | 1.08% | $20.59M |
| Sector gamma as | 433.01K | 1.03% | $4.75M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.41M | 0.01% | 1.41M |
| Aqr capital management | 3.13M | 0.01% | 1.00M |
| Blackrock funding, inc. /de | 10.51M | 0.00% | 871.70K |
| Goldman sachs group | 2.27M | 0.00% | 831.70K |
| State street | 5.33M | 0.00% | 817.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -5.41M |
| Paradigm biocapital advisors lp | - | - | -4.33M |
| Ra capital management | - | - | -4.00M |
| Ecor1 capital | 872.50K | 0.37% | -3.33M |
| Avoro capital advisors | - | - | -2.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.41M | 0.01% | 1.41M | $15.47M |
| Sixth street partners management company | 676.40K | 0.00% | 676.40K | $7.42M |
| Royce & associates lp | 609.99K | 0.05% | 609.99K | $6.69M |
| Jupiter asset management | 509.89K | 0.03% | 509.89K | $5.59M |
| Ally bridge group (ny) | 290.00K | 2.81% | 290.00K | $3.18M |
Sold Out
| Holder | Change |
|---|---|
| Wealthspire advisors | -10.00 |
| Advisory services network | -14.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Principal securities | -18.00 |
| Main street group | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 225 | -1.32% | 87,530,151 | 3.68% | 98 | 1.09% | 122 | 15.09% | 62 | -24.39% |
| Mar 31, 2026 | 122 | -44.55% | 29,094,977 | -65.91% | 33 | 0.35% | 62 | -53.73% | 40 | -21.57% |
| Dec 31, 2025 | 155 | -25.12% | 49,542,038 | -40.99% | 56 | 0.62% | 92 | -22.69% | 38 | -26.92% |
| Sep 30, 2025 | 197 | 7.07% | 77,024,381 | -6.25% | 87 | 1.00% | 112 | -0.89% | 50 | 16.28% |
| Jun 30, 2025 | 183 | -2.14% | 82,143,917 | 5.53% | 93 | 1.18% | 112 | 16.67% | 43 | -24.56% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.80M | 3.15% | 165.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.80M | 3.15% | 165.40K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.80M | 3.15% | - |
| State Street® SPDR® S&P® Biotech ETF | 2.56M | 2.88% | -48.90K |
| Vanguard US Total Market Shares ETF | 2.17M | 2.68% | 3.54K |
| iShares Russell 2000 ETF | 2.20M | 2.47% | -25.34K |
| HBM Healthcare Investments AG Ord | 1.79M | 2.01% | - |
| SPDR® S&P Biotech ETF | 1.28M | 1.48% | 2.86K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.03M | 1.16% | 2.21K |
| Fidelity Small Cap Index | 928.99K | 1.04% | 7.38K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | $88.62K |
| Sep 29, 2026 | FORD KATHLEEN | Chief Operating Officer | Sell | $39.44K |
| Sep 28, 2026 | FORD KATHLEEN | Chief Operating Officer | Sell | $72.49K |
| Sep 28, 2026 | Leoni Mollie | Chief Medical Officer | Sell | $130.67K |
| Sep 29, 2026 | Leoni Mollie | Chief Medical Officer | Sell | $309.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 2 | 12 |
| 2026 Q2 | - | 5 |
| 2026 Q1 | - | 16 |
| 2025 Q4 | - | 7 |
| 2025 Q3 | 3 | 6 |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools